Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D000921:Antibody-Producing Cells / Q000637:transplantation*; D001681:Biological Assay; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006087:Graft vs Host Reaction; D006648:Histocompatibility; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000276:immunology*; D008198:Lymph Nodes / Q000166:cytology; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008806:Mice, Inbred AKR; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm; D003520:Cyclophosphamide